Utah Medical Products reports Q2/H1 2023 results; details not available in filing excerpt

UTAH MEDICAL PRODUCTS INC

2023-Q2 EPS reported $2.31 revenue$25,386,000

Filing references a press release with financial results for three and six months ended June 30, 2023.
Specific revenue, EPS, or segment figures are not included in the provided text.
Forward-looking statements for 2023 and beyond are mentioned but content is unavailable.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.